Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/17/2025

Lamotrigine Therapy Guidelines

Introduction to Lamotrigine Use

  • Lamotrigine is commonly used for epilepsy (partial seizures, primary generalized tonic-clonic seizures) and bipolar disorder (maintenance treatment) 1

Drug Interactions

  • The American Medical Eligibility Criteria for Contraceptive Use classifies the use of combined hormonal contraceptives (CHCs) with lamotrigine as Category 3 (risks generally outweigh benefits), as CHCs can decrease lamotrigine levels 1
  • Enzyme-inducing antiepileptic drugs (carbamazepine, phenytoin, phenobarbital) can decrease lamotrigine levels 1
  • Valproate can increase lamotrigine levels by inhibiting glucuronidation 1

Dosing and Monitoring

  • The American Academy of Neurology recommends gradual tapering of lamotrigine over 4 weeks, reducing by 25-33% of the original dose weekly, when discontinuation is necessary 2
  • Oral loading of lamotrigine appears safe in patients with previous lamotrigine exposure and no history of rash, according to studies published in 2014 3

Safety and Adverse Effects

  • Abrupt discontinuation of lamotrigine may increase seizure risk even in patients taking it for mood disorders, as reported by the American Academy of Neurology 2
  • Lamotrigine can cause serious rashes, including Stevens-Johnson syndrome and toxic epidermal necrolysis, with a higher risk associated with rapid dose escalation, concurrent valproate use, and in pediatric patients 1